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Abstract (250) 
Objective: Defects in insulin signalling pathway have been implicated in the pathogenesis of 
impaired glucose uptake, insulin resistance and type II diabetes. However, the specific 
defects that precipitate these abnormalities are yet to be fully elucidated. The plasma 
membrane embedded insulin receptor transmembrane protein, after binding to insulin, 
initiates a cascade of phosphorylation which leads to the activation of protein kinase B 
(AKT) and subsequently to initiation of some metabolic actions of insulin. The activities of 
this receptor, insulin binding and tyrosine kinase activation, is dependent on its plasma lipid 
environment. There are scarcity of published data on the influence of omega-3 and -6 
polyunsaturated fatty acids on insulin response. Moreover, the findings of the published 
investigations, most of which have used omega-3 and -6 PUFA blend, have been 
inconclusive. Hence, a need for well- thought-out further research. The aim was to elucidate 
the effect of treatments with LNA, ARA, ALA, DHA, and EPA on cell membrane 
composition and consequently on insulin signalling pathway, specifically AKT 
phosphorylation. 
Research Methods and Procedures: Human colon adenocarcinoma (HT29) and liver 
hepatocellular (HepG2) cells were treated with or without 40 µM of linoleic (LNA), 
arachidonic (ARA), alpha-linolenic (ALA), eicosapentaenoic (EPA) or docosahexaenoic 
(DHA) for 48 hours. Fatty acids composition of phosphatidylcholine (PtdCho) and 
phosphatidylethanolamine (PtdEtn) from the treated cells by capillary gas liquid 
chromatograph. Cells were incubated for 30 minutes with or without human insulin 
(50ng/ml) and the phosphorylation of AKT assessed with the use of western blotting. 
Results: The fatty acids were incorporated in PtdCho and PtdEtn of both cell lines; but, the 
level of incorporation was higher in HT29. Phosphorylation of AKT increased when HT29 
was treated with LNA (P<0.05) and ARA (P<0.01), but not with ALA, EPA or DHA. A 
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similar but non-significant increase in AKT phosphorylation was observed in LNA and ARA 
treated HepG2 cells. Conclusion: The finding of this investigation demonstrates, plasma 
membrane lipid bilayer enrichment with LNA or ARA treatment enhances insulin action by 
AKT activation. 
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 Highlights  
 Levels of linoleic (LNA), arachidonic (ARA), alpha-linolenic (ALA), eicosapentaenoic 
(EPA) and docoshexaenoic (DHA acids, and protein kinase B (AKT) phosphorylation 
were  assessed in HepG2 and HT29 cells treated with the fatty acids. 
 LNA and ARA were more efficiently incorporated in HT29 than in HepG2 cells.  
  Phosphorylation of AKT increased significantly in HT29 cells treated with LNA and 
ARA, but not with ALA, EPA or DHA. 
 A non-significant increase in AKT phosphorylation was observed in LNA and ARA 
treated HepG2 cells 
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Introduction 
Alterations of polyunsaturated fatty acid (PUFA) membrane composition have been proposed 
to alter cellular functions including cellular response to insulin. Defects in insulin signalling 
pathway are responsible for insulin resistance and type 2 diabetes [1–3], thus the 
understanding of insulin transduction pathway is of clinical importance.  
 
Human and animal studies have suggested that long chain PUFA, in particular of the omega-
3 family, may be protective against type 2 diabetes and insulin resistance [4]. 
Epidemiological studies showed that consumption of diets high in omega-3 PUFA correlated 
with lower incidence type 2 diabetes compared with diets rich in saturated fatty acids [5–7]. 
Studies on fatty acid membrane composition showed that low levels of omega-3 PUFA were 
found in association with type 2 diabetes [8], whilst insulin sensitivity positively correlated 
with high levels of total omega-3 and -6 PUFA [9]. Similarly, an enhanced insulin sensitivity 
has been reported in experimental animal studies fed on omega-3 and -6 PUFA [10, 11]. 
 
Insulin is a pancreatic hormone involved in many functions. Mainly, it regulates the uptake of 
glucose (the entry of glucose into cells) in muscles, adipose tissue and liver [12]. In addition, 
it is involved in the regulation of several metabolic enzymes, as well as the promotion of 
storage of incoming glucose as glycogen, and synthesis of proteins and triglycerides from 
free fatty acids.  
 
Insulin binds to the insulin receptor [13], a transmembrane heterotetrameric tyrosine kinase 
receptor, which consists of two extracellular ligand-binding α subunits and two 
transmembrane catalytic β subunits. After insulin binds to the IR, IR undergoes 
autophosphorylation of tyrosine residues in the β domains. The activation of the receptor 
6 
 
leads to the recruitment of an adaptor protein, the insulin receptor substrate 1 and 2 (IRS-1 
and 2). The main target of IRS is the phosphatidylinositol 3-kinase (PI3K) [14]. After 
phosphorylation, PI3K converts the phosphatidylinositol 4,5-bisphosphate (PtdIns-4,5-P2) to 
phosphatidylinositol 3,4,5-triphosphate (PtdIns-3,4,5-P3). A key effector of PtdIns-3,4,5-P3 is 
the protein kinase B (PKB), also known as AKT. AKT has a pleckstrin homology domain 
located at its amino terminus, which binds to PtdIns-3,4,5-P3, and permits the recruitment of 
AKT to the plasma membrane [15] .  Once located at the membrane, AKT is firstly 
phosphorylated at 308-Thr residue and subsequently at 473-Ser residue. The phosphorylation 
of the 308-Thr residue is due to the PDK1 protein, which as AKT presents a PtdIns-3,4,5-P3 
binding pleckstrin homology domain [16]. The mechanism of 473-Ser phosphorylation is still 
controversial. The phosphorylation of both the 308-Thr and 473-Ser residues is necessary for 
AKT full activation. Activated AKT dissociates from the plasma membrane and 
phosphorylates several substrates involved in insulin dependent responses. A major effect of 
activated AKT is the promotion of the translocation of the insulin dependent glucose 
transporter 4 (GLUT4) to plasma membrane and subsequent uptake of glucose into cells.  
 
Defects in both upstream and downstream targets of Akt, PI3K-Akt signalling pathway, have 
been implicated in insulin resistance [17, 18]. Insulin receptors are proteins localised in 
plasma membrane, and phosphorylation of PI3K is dependent on inositol containing 
membrane phospholipids. Therefore, it is tenable to assume that changes in plasma 
membrane composition would have an effect on insulin-signalling pathway. Cultured cells 
are widely used good model for investigating relationships between membrane fatty acids 
and insulin response.  In vitro, alterations in lipid composition of erythroleukemia cells and 
ascites cells showed a high percentage of linoleic acid (LNA) rich oil (sunflower oil) versus 
oil containing mainly saturated fatty acids (coconut oil) was associated with an increase in 
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insulin receptor number and a decrease in binding receptor affinity[19, 20]. Bruneau et al. 
[21] demonstrated that lipid alterations (via treatments with LNA) of rat hepatoma cells led to 
an insulin-resistant state. Subsequently, the same group reported that feeding human 
hepatoma cells with LNA and eicosapentaenoic acid (EPA) modified insulin receptor 
autophosphorylation and the phosphorylation of the major insulin receptor substrate, IRS-
1[22] . 
 
The aforementioned studies, most of which have used a heterogeneous blend of omega-3 and 
-6 PUFA, have highlighted a possible relationship between these fatty acids and insulin 
response. Therefore, there is need for further investigations to help elucidate the effect of the 
individual fatty acid members of the two PUFA families.  
 
In the present study, human colon adenocarcinoma (HT29) and hepatocellular carcinoma 
(HepG2) cell lines were used as in vitro systems to study whether alterations of 
phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn) fatty acid composition 
alter insulin-induced AKT activation/phosphorylation. Both cell lines express a functional 
insulin pathway [22, 23]. Although the gastrointestinal tract is the main target of insulin, it is 
where nutrients are processed and absorbed. Consequently, it is thought to have an indirect 
effect on insulin resistance [24]. The liver is widely-recognised primary insulin target and 
hepatocytes are often used to investigate insulin response [25, 26].  
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Material and Methods 
Reagents 
-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic 
acid (LNA) and arachidonic acid (ARA) were purchased from Sigma-Aldrich, dissolved in 
100% ethanol, and stored at -20 0C. Insulin Human recombinant was obtained from Sigma-
Aldrich. 
 
Cell culture  
The human colonic adeno carcinoma cells (HT29) (ECACC) and Human hepatocellular liver 
carcinoma cell line (HepG2) were cultured respectively in Mc`Coys or DMEM medium 
(Sigma) supplemented with 2 mM glutamine, 5 mM streptomycin, 5 mM penicillin and 10% 
foetal bovine serum (FBS) (PAA) at 37 0C  in a humidified atmosphere of 95 % air and 5% 
CO2. 
 
Fatty acid treatments 
HT29 and HepG2 cells (2X105cells/ml) were seeded in 21 cm2 plates and allowed to attach 
and divided for 24 hours. Subsequently, medium was siphoned and replaced with fresh 
medium containing 10% FBS with or without 40 µM of different polyunsaturated fatty acids 
(ALA, EPA, DHA, LNA or ARA) [27, 28]. After 48 hours, treated and untreated cells were 
collected and used for analysis of fatty acids composition. The final concentration of 
ethanol/medium, which was less than 0.1% (v/v%), did not affect cell proliferation.  
 
Fatty acid analysis 
HT29 and HepG2 cells were washed twice with 2 ml per well of 1X PBS. In order to extract 
cell membrane total lipids, 1.5 ml of hexane/isopropanol (3:2, v/v) (HIP) and 0.01% BHT 
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was added to each well on ice. After 5 minutes of incubation on a shaker, the HIP mixture 
was transferred to a clean glass tubes. The HIP mixture was completely evaporated under 
nitrogen, and 1.8 ml of chloroform/methanol (2:1, v/v) + BHT, plus 0.6 ml of water were 
added to the tubes. The tubes were vortexed and then centrifuged at 4000 rpm for 5 minutes 
at 4 °C. After centrifugation, the lipid enriched organic phase was collected, the solvent was 
completely evaporated under nitrogen and the lipids were dissolved in 1 ml 
chloroform/methanol (2:1, v/v). Phosphatidylcholine (PtdCho) and phosphatidylethanolamine 
(PtdEtn) were separated by thin-layer chromatography on 20x20 cm silica gel plates (TLC 
silica gel 60, Merck kGaA, UK) by the use of the developing solvents: 
chloroform/methanol/methylamine (65:30:15, v/v) and 0.01% BHT. The phospholipid bands 
were detected by spraying the plates with a 2,7-dichloroflurescein/methanol solution (0.01 % 
w/v) and identified by the use of standards. Fatty acid methyl esters (FAMEs) were prepared 
by heating the lipid fractions with a 4 ml of 15% acetyl chloride in methanol in a sealed vial 
at 70 0C for 3 hours under nitrogen. FAMEs were separated by a capillary gas liquid 
chromatograph (HRGC MEGA 2 Series, Fisons Instruments, Italy) and identified by 
comparison of retention times of authentic standards (Sigma-Aldrich, United Kingdom) and 
by calculation of equivalent chain length values. Peak areas were quantified by a computer 
chromatography data system (Agilent EZChrom Elite 3.2, Scientific Software, Inc., 
Pleasanton, CA). 
 
Insulin treatments 
HT29 and HepG2 cells (2X105/ml) were seeded in 21 cm2 plates and allowed to attach and 
divide for 24 hours. Subsequently, the old medium was siphoned off and replaced with fresh 
medium containing 10 % FBS supplemented with 40 μM of different polyunsaturated fatty 
acids (ALA, EPA, DHA, LNA or ARA). Two plates were grown in 10 % FBS medium 
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without adding fatty acids. After 48 hours of incubation, the old medium was discarded and 
the cells incubated in fresh serum free medium for 6 hours. Subsequently, the medium was 
siphoned off, and the cells incubated for 30 minutes with fresh medium with and without 
50ng/ml of human insulin [29].  
 
Western blot 
HT29 and HepG2 cells were washed twice with ice cold PBS 1X. Subsequently, cells were 
lysed in ice-cold RIPA buffer (1% NP-40, 0.1% SDS, 0.5% deoxycholate, 20mM Tris-HCl 
buffer (pH 7.4), 150 mM NaCl, 10 mM NaF, 1 mM Na3VO4, 1 mM EDTA, 1 mM EGTA). 
To prevent protein degradation and dephosphorylation, phosphatase and protease inhibitor 
cocktail (Sigma-Aldrich, UK) were added to the RIPA buffer. The lysed cells were 
transferred to a clean 1.5 ml tube and the insoluble material removed by centrifugation 
(13,000×g at 4°C for 20 min). The supernatant was transferred to a new chilled tube and its 
protein content quantified by Bradford Protein Assay. 40 µg of proteins were diluted in 3X 
Laemmi loading buffer (1.5% Tris-HCl buffer (pH 6.8), 4% SDS, 1% glycerol, 0.2 % 
bromophenol blue, 0.4% β-mercaptoethanol in water) and loaded on a 10% Sodium Dodecyl 
Sulphate (SDS) –polyacrylamide mini gel (Biorad apparatus). The separated proteins were 
transferred from the gel on to a nitrocellulose membrane (Biorad) using a Mini Trans-Blot 
Cell apparatus at 0.09 mA overnight. The membranes were blocked for 1 hour in 5% dried 
non-fat milk in TBS-T 1X then washed three times in TBS-T 1X buffer. Subsequently, 
membranes were blotted with Rabbit Anti-phospho-Akt (Ser473) (1:1000, Cell Signaling 
technology) in 5% BSA/TBST 1X overnight at 4°C. After incubation, membranes were 
washed 3 times for 5 minutes in TBS-T 1X and incubated with Goat anti-rabbit IgG HRP 
conjugate secondary antibody in 5% nonfat dry milk in TBST 1X  for one hour at room 
temperature. After probing with secondary antibody membranes were washed 3 times for 5 
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minutes in TBS-T 1X. Proteins signals were revealed by enhanced chemiluminescence 
(Immobilon western HRP substrate, Millipore) in the dark with the use of X-Ray films, 
developing and fixing reagents. After detection, the membranes were stripped and re-probed 
with and Rabbit anti-AKT (1:1000, Cell Signaling technology) in 5% BSA/TBST 1X 
overnight at 4 °C. After incubation, membranes were washed 3 times for 5 minutes in TBST 
1X and incubated with Goat anti-rabbit IgG conjugate secondary antibody in 5% dried non-
fat milk in TBS-T 1X for one hour at room temperature. After probing with secondary 
antibody membranes were washed 3 times for 5 minutes in TBS-T 1X and Akt signal was 
detected by enhanced chemiluminescence (Immobilon western HRP substrate, Millipore) 
with the use of X-Ray films, developing and fixing reagents. The density of the bands was 
quantified by the use of the UVP Vision Works software and the level of the phospho-Akt 
was normalised to the level of the total Akt. 
 
Statistical analysis  
Data were calculated as mean percentage of total fatty acids (± S.E.) and statistical 
significance was set at P<0.05. Unpaired t-test was used to compare the difference in fatty 
acid composition between the different treatments. The statistical software SPSS for 
Windows (version 23, SPSS Inc., Chicago, IL, USA) was employed to analyse the data.  
 
Results 
Omega-3 and omega-6 PUFA induced changes in membrane fatty acid composition of HT29 
and HepG2 cells. 
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HT29 cells 
Incubation with ALA, EPA, DHA, LNA or ARA altered membrane composition of HT29 
cells (Table 1).   
Treatment with ALA increased its level to 26.35% in PtdCho and 32.33% in PtdEtn (P<0.05 
to untreated cells). EPA treatments enhanced the level of EPA from 0.08% to 3.43% in the 
PtdCho (P<0.05 to control cells), and from 2.63% to 8.10% in the PtdEtn (P<0.05 to control 
cells). DHA was mainly incorporated in the PtdEtn fraction. It increased from 2.44% to 
20.43% in the PtdEtn, and from 0.63% to 3.96% in the PtdCho (P<0.005), compared to 
control cells. Incubation with ALA or EPA did not increase the level of DHA in the PtdCho 
or PtdEtn fractions.  
In comparison with control cells, LNA treatments increased LNA percentage from 3.47% to 
40.70% in the PtdCho (P<0.05) and from 3.14% to 28.96% in the PtdEtn (P <0.05). 
Treatment with LNA did not increase the level of ARA in neither the PtdCho nor the PtdEtn. 
Incubation with ARA enhanced ARA to 19.62% in the PtdCho and to 37.09% in the PtdEtn 
from 0.89% and 5.74%, respectively (P <0.05) compared to control cells. The percentage of 
adrenic acid (ADA, 22:4n-6) or docosapentaenoic acid (DPA-6, 22:5n-6) was not affected by 
ARA treatments (data not shown) in neither the PtdCho nor the PtdEtn. 
 
HepG2 cells 
The fatty acid profile of HepG2 cells after supplementation with ALA, EPA, DHA, LNA and 
ARA is shown in Table 2.  
After incubation with ALA, the level of ALA increased from 0.15% to 11.31% (P<0.01) in 
the PtdCho, and from 0.07% to 9.15% (P<0.05) in the PtdEtn, compared to control cells. 
EPA increased to 0.61% and 1.64 % in the PtdCho and PtdEtn fractions (P<0.05 to control 
cells). DHA was preferentially incorporated into the PtdEtn fraction with an increased from 
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4.21% to 38.83% (P<0.05), rather than to the PtdCho fraction where it was enhanced from 
1.76% to 12.76% (P<0.01), compared to control cells. There was no increase in DHA in the 
PtdCho or PtdEtn as a result of incubation with ALA. Incubation with EPA slightly increased 
the level of DHA. 
LNA was mainly incorporated in the PtdCho where it increased from 5.76% to 29.98% 
(P<0.01), whilst it was enhanced from 4.46% to 18.92% (P<0.01) in the PtdEtn, compared to 
untreated cells. Incubation with LNA did not enhance the level of ARA in the PtdCho or 
PtdEtn. ARA supplements significantly enhanced ARA level from 2.49% to 19.76 % in the 
PtdCho (P<0.01) and from 5.93% to 13.59 % in the PtdEtn (P<0.01), compared to untreated 
cells. After ARA incubation, the percentage of ADA increased from 0.86% to 19.89% in the 
PtdCho (P<0.005) and 0.89% to 20.88% in the PtdEtn (P<0.005) (data not shown). 
 
 Changes in membrane PUFA composition alter AKT phosphorylation in HT29 and 
HepG2 cells.  
Cells treated with insulin only or pre-treated with fatty acids and then incubated with insulin 
showed enhanced phosphorylation of the Akt protein compared to control cells with no 
insulin (P<0.05) (Figure 1a).  
Pre-treatment with ALA, EPA and DHA before insulin stimulation did not alter the 
phosphorylation level of Akt compared to insulin only stimulated cells (Figure 1a).  
Pre-treatment with LNA and ARA before insulin stimulation increased the amount of Akt 
phosphorylation compared with insulin only treated cells. This increase was statistically 
significant in HT29 cells (P<0.05 and P<0.01) (Figure 1a). In HepG2 cells, LNA and ARA 
showed a slight but not significant increase in Akt phosphorylation (Figure 1a). 
Further investigation was conducted to elucidate whether the enhancement of Akt 
phosphorylation seen in LNA and ARA treated cells, was dependent on insulin and not 
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merely due to ARA and LNA treatments. Cells treated with LNA and ARA but not insulin 
were compared to untreated cells stimulated with insulin (Figure 2). As expected, insulin 
stimulated-cells responded to insulin by enhancement of Akt phosphorylation. In contrast, 
LNA and ARA did not enhance the level of phospho-Akt, showing that Akt phosphorylation 
is insulin-stimulation dependent.  
 
Discussion and Conclusions 
In this study, we have demonstrated that both HT29 and HepG2 cells incorporate fatty acids 
in PtdCho and PtdEtn - the most abundant cell membrane phospholipids.  Moreover, we have 
shown that the incorporation and resultant changes in membrane phospholipid fatty acid 
composition influences insulin-induced Akt activation. The incorporation of LNA and ARA 
increased significantly insulin-induced Akt phosphorylation in HT29 cells and slightly but 
not significantly in HepG2 cells.  
 
The incorporation of ALA, EPA or DHA did not have any effect on insulin-induced Akt 
phosphorylation in neither of the two cell lines. These findings are inconsistent with previous 
published reports [1, 3].  Supplementation of rats with fish oil improved insulin sensitivity by 
increasing insulin binding and receptor number [11], and enhanced insulin-stimulated glucose 
transport [30] . These contradicting observations could be a reflection of the difference 
between in vivo and in vitro investigations.  Moreover, because fish oil contains appreciable 
amounts of LNA and ARA it is not possible to categorically attribute the observed effect on 
inulin sensitivity to EPA and DHA.  
 
The increase in Akt phosphorylation was more remarkable in HT29 than Hep2 cells treated 
with LNA and ARA.  In addition, these fatty acids were more efficiently incorporated by 
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HT29 than HepG2 cells. In the PtdCho, incubation with LNA resulted in a 13-fold increase in 
HT29 and a 6-fold in HepG2 cells. LNA increased 10 and 4.5 fold in HT29 and HepG2 cell 
PtdCho, respectively. Similarly, in PtdCho, ARA incubation enhanced the level of ARA 18 
fold in HT29 and 9.5 in HepG2 cells. ARA increased 7.4 fold HT29 and 2.6 in HepG2 cells 
in PtdEtn.  The observed difference in response to insulin and in fatty acid incorporation 
between HT29 and HepG2 cells is most likely a reflection of their intrinsic characteristics. 
Indeed, it is postulated that the impact of insulin on cell types is different depending on 
relative IR-B: IR-A expression levels [31]. A difference in growth inhibition and apoptosis 
have been observed between HepG2 and HT29 cells treated with dehydroepiandrosterone 
[32].  IR-A isoform is more predominant in HT-29  [31] and IR-B in HepG2 [33].  
 
Our findings of the effect of LNA on Akt phosphorylation is consistent with the reports of 
previous studies. Field et al. [10] demonstrated that rats fed diets containing increasing ratios 
of linoleic acid compared with those fed saturated fatty acids (palmitic and stearic) had 
enhanced insulin binding capacity.  A  higher insulin-stimulated  glucose uptake in  adipocytes 
of rats fed LNA-rich diet compared with those fed a high EPA/DHA diets was demonstrated 
by Fickova et al. [31]. Similarly,  Lee et al. [13] have reported increased insulin sensitivity in 
experimental given n-6 polyunsaturated fatty acids. Meuillet et al. [22], in vitro studies, have 
observed increased IR and IRS1 phosphorylation in HepG2 cells  incubated with LNA.  
 
The findings of the limited studies that investigated the effect of ARA supplementation on 
insulin response have been inconclusive. Borkam et al. [9] found a positive relationship  
between insulin-sensitivity and muscle-ARA level in healthy men. Likewise, Villegas-
Comonfort [32] demonstrated that ARA induces AKT activation in MDA-MB-231 cells.  In 
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contrast, Talukdar and colleagues [33] have reported that ARA inhibits insulin induced Akt 
phosphorylation but promotes IRS-1 phosphorylation in rat hepatocytes.  
 
It is not evident how the uptake of LNA and AA influences positively Akt phosphorylation.  
Phosphorylation of Akt is a complex signalling cascade that involves insulin binding to IR 
and stepwise phosphorylation of IR, IRS-1 and PI3K.  Akt phosphorylation could be 
influence positively or negatively from changes in the aforementioned steps of the signalling 
cascade.   
 
Modification of IR response to insulin by altered membrane composition might be linked to 
changes of cell membrane organisation, such as alterations of rafts and caveolae 
microdomains. Caveolae are thought to act as a platform for the recruitment of several signal 
transduction molecules, including the IR[34, 35] . It appears these membrane microdomains 
are critical for proper compartmentalization of the insulin transduction pathway and their 
modification leads to alterations of insulin transduction cascade. Indeed, there is evidence 
that the disruption of caveolae by depletion of cholesterol inhibits the ability of insulin to 
enhance glucose uptake, and IRS-1 and Akt phosphorylation in cell lines [36].  Similarly, 
impaired IRS-1 and Akt phosphorylation, insulin resistance condition, was observed in rats 
fed a high cholesterol diet [37].  Chapkin et al. [38] have proposed that the aversion of DHA 
and LNA to cholesterol would enhance segregation of cholesterol into lipid microdomains. 
The authors have demonstrated that the above fatty acids increased clustering of proteins in 
cholesterol-dependent microdomains in HeLa cells. The finding has highlighted a differential 
effect of LNA versus DHA indicating that only LNA treatment reduced clustering of proteins 
in non-raft regions. Consistent with the afore cited investigation, pretreatment of endothelial 
cells with LNA increased caveolin-1 expression and p38 MAPK activation [39]. The authors 
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postulated that certain fatty acids may either stabilize or perturb caveolae function, thus 
leading to modification of caveolae-dependent pathways [40].  Similarly, Schley et al. [41] 
demonstrated that LNA treatment of breast cancer cells resulted in higher content of 
cholesterol and sphingomyelin in rafts as compared with DHA and EPA.  In addition, EPA 
and DHA decreased the expression of the epidermal growth factor receptor (EGFR) 
selectively in rafts.  
 
The above studies have highlighted the importance of membrane organisation in cell 
signaling and the link between cell transduction and membrane structure.  Therefore, it is 
tenable to speculate that the enhancement of AKT phosphorylation after treatment with LNA 
might be due to the formation and compartmentalisation of caveolae, lipid-rafts, and their 
interactions with insulin receptors (IR).   
 
After activation, PI3K phosphorylates PtdIns-4,5-P2 to yield PtdIns-3,4,5-P3. The generation 
of PtdIns-3,4,5-P3 is crucial for the recruitment and phosphorylation of AKT and activation 
of PDK1.  There is evidence of selective incorporation of ARA in inositol phosphoglycerides  
[42] and  elevated levels of the fatty acid in PtdIns-4-P and PtdIns-4,5-P2 [39, 43] . A 
question arises whether an increased ARA level in cell membrane alters membrane 
phospholipid metabolism (i.e. accumulation, turnover), particularly of inositol containing 
phospholipids. ARA had an inhibitory effect on PtdIns-1,4-P2/PtdIns-1,4,5-P3 metabolism 
under condition of cycle activation in submandibular acinar cells [44]. In contrast, it  
stimulated the accumulation of inositol mono-bi-and tri-phosphate, but not inositol 
phosphoglycerides in astrocytes [45]. Also, it is reported that ARA PtdCho suppressed Akt 
membrane translocation but left the concentration of the anchor lipid phosphatidylinositol-
3,4,5-trisphosphate unchanged in fibroblasts [46]. The question yet to be answered is whether 
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increased ARA might alter the level of PtdIns-4,5-P2 available for phosphorylation and in 
turn the level of PtdIns-3,4,5-P3 and effect AKT phosphorylation in HT29 cells.     
 
Previous studies have investigated the effect of n-6 and n-3 polyunsaturated fatty acids on 
Akt signaling pathway. However, most of these studies did not investigate whether or not the 
supplemented fatty acids were incorporated into membrane phospholipids. In addition, some 
of these studies have used a mixture of fatty acids from fish oil or vegetable seed oils instead 
of individual fatty acids. The present study is original in that the cells were treated with 
individual fatty acids, and it has established a link between the treatment, specific changes in 
fatty acid composition of the major membrane phospholipids and the subsequent effect on 
Akt phosphorylation.”  
 
The small simple size was a limitation of this study. However, because transformed cells have 
a consistent feature (very low random variations) and a significance difference is established, 
the findings provide new valuable insights into the role of n-6 fatty acids in insulin signaling. 
 
“In conclusion, the findings of the present investigation demonstrates   that modification of 
membrane lipids with LNA or ARA treatment enhances insulin action by activation of AKT. 
Further work is required to establish whether the increased AKT phosphorylation is due to 
altered IR, IRS1 and/or PI3K activation. The expression and membrane localisation of IR and 
its association with caveolae should be elucidated.  Furthermore, it is important to clarify if 
phospholipid levels and PtdIns metabolism are altered as a consequence of changes in 
membrane fatty acid composition.” 
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Figure 1.   Expression of phosphor-AKT (Ser473) after 30 minutes of stimulation with 
                 50ng/ml insulin in HT29 and HepG2 cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a – Graph  
 Level of AKT phosphorylation was normalised to the expression of the AKT total  
protein and expressed as ratio to control untreated cells.  
 Data are expressed mean (± SE) of two independent experiments.  
 Significant difference from insulin stimulated only at p<0.05(*) and p<0.01 (**).  
 
b - Western blot.  
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Figure 2.  Expression of phosphor-AKT (Ser473) after LNA and ARA treatment in  
                HT29 cells. 
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Table 1. Change of omega-3 and omega-6 fatty acid levels in phosphatidylethanolamine (PtdEtn) and phosphatidylcholine (PtdCho) after 
               treatment in HT29 cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 HT29 cells were treated for 48 hours with 40 μM of -linolenic (ALA),  Eicosapentaenoic (EPA), docosahexaenoic (DHA), linoleic (LNA) acids or  
arachidonic acid (ARA).  
 Each experiment was repeated two times or more and the data are expressed as mean (SE) percent total fatty acids. 
  Significant difference from control at p<0.05 (*), p<0.01 (**), p<0.005 (***) 
 
 
 
HT29   
  Fatty Acids %   
    ALA   EPA   DHA   LNA   ARA   
PdtEtn 
CONTROL  0.15 ± 0.15   2.63 ± 1.64   2.44 ± 1.18   3.14 ± 0.06   5.74 ± 3.07   
+ ALA 32.33 ± 4.59 * 2.56 ± 0.75   3.07 ± 0.64   4.79 ± 0.03   6.92 ± 0.78   
+ EPA 0.38 ± 0.06   8.10 ± 0.80 * 1.91 ± 0.23   5.19 ± 0.98   6.32 ± 0.59   
+ DHA 0.11 ± 0.11   13.66 ± 1.74 * 20.43 ± 1.11 ** 2.79 ± 0.18   6.70 ± 0.01   
+ LNA 0.00 ± 0.00   1.88 ± 0.16   2.34 ± 0.31   28.96 ± 4.21 * 6.52 ± 0.13   
+ ARA 1.13 ± 1.13   0.53 ± 0.21   3.18 ± 0.59   2.93 ± 0.60   37.09 ± 1.78 * 
                                            
PdtCho 
CONTROL  0.10 ± 0.10   0.08 ± 0.08   0.63 ± 0.25   3.47 ± 0.46   0.89 ± 0.32   
+ ALA 26.35 ± 3.45 * 0.11 ± 0.11   0.50 ± 0.14   4.72 ± 0.60   0.85 ± 0.31   
+ EPA 0.31 ± 0.31   3.43 ± 0.34 * 1.40 ± 0.07   10.19 ± 0.97   3.40 ± 0.03   
+ DHA 0.09 ± 0.09   3.63 ± 2.07   3.96 ± 0.88 * 3.47 ± 0.95   1.08 ± 0.43   
+ LNA 0.06 ± 0.06   0.10 ± 0.10   0.69 ± 0.20   40.70 ± 6.20 * 1.12 ± 0.27   
+ ARA 0.05 ± 0.05   0.14 ± 0.14   0.90 ± 0.28   3.88 ± 0.66   19.62 ± 6.22 * 
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Table 2. Change of omega-3 and omega-6 fatty acid levels in phosphatidylethanolamine (PtdEtn) and phosphatidylcholine (PtdCho) after 
               treatment in HepG2 cells 
 
HepG2   
    ALA   EPA   DHA   LNA   ARA   
PdtEtn 
CONTROL  0.07 ± 0.07   0.00 ± 0.00   4.21 ± 0.00   4.46 ± 0.72   5.93 ± 0.55   
+ ALA 9.15 ± 0.21 * 0.40 ± 0.40   3.04 ± 1.46   5.49 ± 0.12   5.53 ± 0.14   
+ EPA 0.13 ± 0.13   1.64 ± 0.10 * 6.63 ± 1.93   4.60 ± 0.51   6.85 ± 0.40   
+ DHA 0.05 ± 0.05   1.50 ± 0.48   38.83 ± 6.16 * 2.63 ± 1.21   2.24 ± 0.04   
+ LNA 0.00 ± 0.00   0.17 ± 0.17   7.17 ± 0.81   18.92 ± 1.00 ** 4.88 ± 0.11   
+ ARA 0.04 ± 0.04   0.06 ± 0.06   4.13 ± 0.51   2.89 ± 1.28   13.59 ± 1.67 ** 
                                            
PdtCho 
CONTROL  0.15 ± 0.08   0.15 ± 0.08   1.76 ± 0.85   5.76 ± 0.93   2.49 ± 1.05   
+ ALA 11.31 ± 0.42 * 0.10 ± 0.10   0.68 ± 0.09   4.23 ± 0.62   1.29 ± 0.20   
+ EPA 0.10 ± 0.10   0.61 ± 0.28 * 2.00 ± 1.03   5.90 ± 0.90   3.31 ± 1.87   
+ DHA 0.09 ± 0.09   2.33 ± 0.60 * 12.76 ± 0.80 ** 4.06 ± 0.09   2.43 ± 0.18   
+ LNA 0.05 ± 0.05   0.00 ± 0.00   0.66 ± 0.01   29.98 ± 4.66 ** 0.86 ± 0.02   
+ ARA 0.00 ± 0.00   0.00 ± 0.00   2.24 ± 0.29   4.09 ± 0.51   19.76 ± 2.01 ** 
             
HepG2 cells were treated for 48 hours with 40 μM of -linolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LNA) or arachidonic 
 acid (ARA); each experiment was repeated two times or more the data is expressed mean (SD) percent total fatty acids.  Significant difference from control at p<0.05 (*),  
p<0.01 (**), p<0.005 (***) 
